Cervarix
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Made by
- GlaxoSmithKline Biologicals S.A.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Cervarix is a vaccine for use from the age of 9 years for the prevention of premalignant ano-genital lesions (cervical, vulvar, vaginal and anal) and cervical and anal cancers causally related to certain oncogenic Human Papillomavirus (HPV) types. See sections 4.4 and 5.1 for important information on the data that support this indication. The use of Cervarix should be in accordance with official recommendations.
From the official label · 2026-09-30 · European Medicines Agency
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | GlaxoSmithKline Biologicals S.A. |
|---|---|
| Active substance | Human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed) |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J07BM02 · Antibiotics, antivirals and antifungals taken into the body |
| Authorised on | 2007-09-20 |
| Last updated by the regulator | 2026-07-09 |
| EMA product number | EMEA/H/C/000721 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).